MSDS 115-500
MSDS 116-500
MSDS 116-GS
MSDS 116A-500
MSDS 116F-500
MSDS 116K-500

Description

Medium carefully optimized for the characteristics and requirements unique to Human Fibroblasts.  Attention to detail ensures ideal cell health, viability, performance, physiology, morphology, consistency and data.
 
Use with:
Human Dermal Fibroblast Media

Details

CAI media are tested for sterility in order to confirm no bacteria, yeast or fungi contaminate the solutions.  The products undergo further quality control for correct pH, osmolality and lack of endotoxins. A panel of different bioassays affirm the media sustain a proper environment for expected cell-type-specific culture, growth, plating, karyotype, physiology, morphology, viability, population doublings, surface markers, cryopreservation, differentiation and/or induction.
 
Laboratory research use only (RUO). Not for human, clinical, diagnostic or veterinary use.

Products

Product Size CAT.# Price Quantity
HDF Growth Medium: All-in-one ready-to-use Size: 500 ml CAT.#: 116-500 Price: $99.00
-+
HDF Growth Medium Kit: Basal medium & growth supplement sold together packaged separately. Size: Yields 500 ml CAT.#: 116K-500 Price: $118.00
-+
HDF Growth Supplement: Added to Basal Medium to create Growth Medium. Size: 15 ml CAT.#: 116-GS Price: $51.00
-+
HDF Basal Medium: Basal medium (contains no growth supplement). Add GS before use. Size: 500 ml CAT.#: 115-500 Price: $57.00
-+
HDF Growth Medium wo Antibiotics: Growth medium without antibiotics Size: 500 ml CAT.#: 116A-500 Price: $118.00
-+
Human Dermal Fibroblast Growth Medium, Xeno-Free: All-in-one ready-to-use Xeno-Free for HDF  Size: 500 ml CAT.#: 116XF-500 Price: $119.00
-+

Related Products

Product Size CAT.# Price Quantity
Freezing Medium: For general cryopreservation of most primary cells. Contains FBS & DMSO. Size: 50 ml CAT.#: 040-50 Price: $54.00
-+
Subculture Reagent Kit: 100 ml each of HBSS, Trypsin/EDTA & Trypsin Neutralizing Solution Size: 1 Kit CAT.#: 090K Price: $55.00
-+

Extended Family Products

Product Size CAT.# Price Quantity
Cytofect™ Fibroblast Transfection Kit: 250 x 24-Well Rxns Size: 1 Kit CAT.#: TF103K Price: $404.00
-+
Cytofect™ Fibroblast Transfection Kit: 25 x 24-Well Rxns Size: 1 Sample Kit CAT.#: TF103KS Price: $54.00
-+
Cyto-X Cell Counting Reagent: 500 tests Size: 1 Bottle CAT.#: 028-01 Price: $139.00
-+
Cyto-X Cell Counting Reagent Sample: 100 tests Size: Sample CAT.#: 028-S Price: $36.00
-+

Resources/Documents

Publications

2010
Xu, C. 2010. Reprogramming of somatic cells with purified proteins. Patent Application US 20120115225 A1.
2010
Xu, C. 2010. Reprogramming of somatic cells with purified proteins. Patent Application US 20120115225 A1.
2016
Connor, B., D. Mirella and C. Maucksch. 2016.  Cell Programming. Patent Application US 20160122712 A1.
Czubryt, M. 2016. Inhibition of collagen synthesis. Patent US 9238685 B2.
Hookway, T., J. Butts, E. Lee, H. Tang and T. McDevitt. 2016. Aggregate formation and suspension culture of human pluripotent stem cells and differentiated progeny. Methods, 101:11-20.
2015
Saito, K., N. Fukuda, K. Shinohara, Y. Masuhiro, S. Hanazawa, H. Matsuda, K. Fujiwara, T. Ueno and M. Soma. 2015. Modulation of the EMT/MET process by pyrrole–imidazole polyamide targeting human transforming growth factor-β1. Intl J Biochem & Cell Biol, 66:112-120.
Rolfes, E., J. Ross, J. McGonigle, G. Opperman and S. Chudzik. 2014. Poly-α(1→4)glucopyranose-based matrices with hydrazide crosslinking. Patent US8790701 B2.
2012
Czubryt, M. 2012. Inhibition of collagen synthesis. Patent Application US 20140288003 A1.
Mahasiripanth, T., S. Hokputsa, S. Niruthisard, P. Bhattarakosol, and S. Patumraj. 2012. Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer. Cancer management and research. 4:269.
Maucksch, C., E. Firmin, C. Butler-Munro, J. Montgomery, M. Dottori, andn B. Connor. 2012. Non-Viral Generation of Neural Precursor-like Cells from Adult Human Fibroblasts. J Stem Cells Regen Med, 8:162-170.
Ohta, K. 2012. Method for producing pluripotent cell using bacterium having fermentation ability. Patent Aplication US 20140255942 A1. Ohta, K., R. Kawano, and N. Ito. 2012. Lactic acid bacteria convert human fibroblasts to multipotent cells. PloS one. 7:e51866-e51866.
Rim, J.S., K.L. Strickler, C.W. Barnes, L.L. Harkins, J. Staszkiewicz, J.M. Gimble, G.H. Leno, and K.J. Eilertsen. 2012. Temporal epigenetic modifications differentially regulate ES cell-like colony formation and maturation. Stem Cell Discovery. 2:45-57.
2011
Bogaard, H.J., S. Mizuno, A.A.A. Hussaini, S. Toldo, A. Abbate, D. Kraskauskas, M. Kasper, R. Natarajan, and N.F. Voelkel. 2011. Suppression of Histone Deacetylases Worsens Right Ventricular Dysfunction after Pulmonary Artery Banding in Rats. American journal of respiratory and critical care medicine. 183:1402-1410.
Connor, B., M. Dottori, and C. Maucksch. 2011. Cell programming. Patent Application US 20120301965 A1.
Czubryt, M. 2011. Modulation of scleraxis using a dominant negative scleraxis mutant with a basic dna-binding domain deletion. Patent Application US 20130123198 A1.
Gao, Z., M.S. Xu, T.L. Barnett, and C.W. Xu. 2011. Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochemical and biophysical research communications. 407:271-276.
Singh, M. and A. Sharma. 2011. Outgrowth of fibroblast cells from goat skin explants in three different culture media and the establishment of cell lines. In Vitro Cell Dev Biol, 47:83-88.
Zheng, M., D.M. Jones, C. Horzempa, A. Prasad, and P.J. McKeown-Longo. 2011. The first type III domain of fibronectin is associated with the expression of cytokines within the lung tumor microenvironment. Journal of Cancer. 2:478.
2010
Peng, H., O.A. Carretero, E.L. Peterson, and N.-E. Rhaleb. 2010. Ac-SDKP inhibits transforming growth factor-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts. American J. of Physiology 298:H1357-H1364.
Xu, C. 2010. Reprogramming of somatic cells with purified proteins. Patent Application US 20120115225 A1.
2009

Fusaki, N., H. Ban, A. Nishiyama, K. Saeki, and M. Hasegawa. 2009. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proceedings of the Japan Academy, Series B. 85:348-362.